Daily Newsletter

05 September 2023

Daily Newsletter

05 September 2023

Push for more NHS organisations to get involved in clinical research

Professor Lucy Chappell hopes that research will be more common in the NHS with hospital trusts and GP practices getting involved.

Abigail Beaney September 05 2023

There is hope that everyone in the UK's National Health Service (NHS) to get involved in clinical research, said professor Lucy Chappell, chief scientific adviser to the Department for Health and Social Care.

During her keynote speech at the Arena International Outsourcing Clinical Trials UK and Ireland 2023 Conference in London, Chappell said that there should be a more proactive approach from those in the NHS to provide research to patients as part of the UK Clinical Trials Recovery, Resilience and Growth (RRG) programme.

The number of participants being involved in trials dropped but is now growing again

UK Government data shows the number of participants in commercial research has substantially declined from more than 50,000 patients in 2017 to 2018 to just over 28,000 in 2021 to 2022.

Chappell said that numbers are growing again but in a further bid to improve the research efforts in the country, there are hopes that those in the NHS can provide more treatment options to patients through clinical trial regardless of whether the doctor is directly involved in the research.

Chappell said: “You've got three options, you can be research aware, you can be research active or you can be a research leader but the option that isn't on the table is to be a research blocker. You can't stop it from happening. If we brought everyone to even the first level of instruction where they signpost patients to that research, is that so hard?”

Chappell added that not only will involvement in clinical research improve the country’s contributions to the sector but also provide a better patient outcome.

She added: “The potential is there are better patient outcomes, better for the workforce, better for the system. Who wouldn't want to have research embedded in their practice? And how do we systematically remove those barriers?”

Questions raised about the feasability of more research involvement

Questions were raised about both the availability of research in care home facilities and the feasibility of conducting research in the NHS given the current strain on doctors but Chappell said that the research model will run alongside the NHS long-term health plan to ensure that the ability to contribute to research is available for everyone.

“My vision is health and care research and I think we are only at the foothills of research in the local authority, public health, and care homes,” Chappell concluded.

“I'm quite clear that is where we are going to see new advances.”

M&A in the Contract Manufacturing Industry

Despite challenging business conditions in 2021 and 2022, large CMOs were still involved in acquisitions to enhance their capabilities or scale of production. Catalent and Recipharm were particularly active in acquiring companies during this period, and these acquisitions had a focus on advanced biologic capabilities related to cell and gene therapies. CMOs are increasingly targeting companies with sophisticated (biologic and specialized) capabilities to manufacture modern drugs and seek high-value contracts.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close